MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.drugpo.2025.104898

Медицинская библиотека · The International journal on drug policy · 2025

Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, Vietnam.

Trickey Adam, Walker Josephine G, Khue Pham Minh, Hong Tran Thi, Binh Nguyen Thanh, Quillet Catherine, Vallo Roselyne, Bivegete Sandra, Oanh Khuat Thi Hai, Fraser Hannah, Huong Duong Thi, Pollack Todd, Nhung Vo Thi Tuyet, Jarlais Don Des, Vinh Vu Hai, Nagot Nicolas, Laureillard Didier, Stone Jack, Vickerman Peter

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

In Haiphong, Vietnam, most hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). As part of multiple respondent-driven sampling (RDS) surveys among PWID in Haiphong, an intervention (DRIVE-C) provided HCV testing and treatment in 2019. Centres providing opiate agonist treatment (OAT) or antiretroviral therapy (ART) also provided HCV testing and linkage-to-treatment in 2021/22. We modelled the impact and cost-effectiveness of HCV testing and treatment for PWID in Haiphong.

METHODS

An HCV transmission model among PWID and former injectors was calibrated in a Bayesian framework using data from Haiphong. A status quo (SQ) scenario modelled past interventions, with no future HCV treatment. A future intervention scenario modelled the impact of providing HCV testing and linkage-to-treatment in OAT and ART centres, and annual RDS survey interventions over 2025-2030, each testing 1400 PWID. We estimated the incremental cost-effectiveness ratio (ICER) per disability adjusted life-year (DALY) averted for the future scenario compared to SQ over 2025-2054 (3 % annual discount rate).

RESULTS

For the SQ scenario, HCV incidence decreased from 8.1 (95 % credibility interval 5.1-13.6) per 100 person-years (/100pyrs) in 2015 to 5.3/100pyrs (3.0-9.6) in 2023 and increases to 6.2/100pyrs (3.5-10.7) in 2030. In the future intervention scenario, incidence decreases to 2.7/100pyrs (1.0-6.4) by 2030. The mean ICER is €884/DALY averted; cost-effective at a willingness-to-pay threshold of €2334 (57 % of Vietnam's 2023 GDP per capita).

CONCLUSIONS

Using RDS surveys and other care settings to scale-up HCV-testing and treatment are cost-effective strategies to reduce HCV incidence among PWID in Vietnam.

Для цитирования: Trickey Adam, Walker Josephine G, Khue Pham Minh, Hong Tran Thi, Binh Nguyen Thanh, Quillet Catherine, Vallo Roselyne, Bivegete Sandra, Oanh Khuat Thi Hai, Fraser Hannah, Huong Duong Thi, Pollack Todd, Nhung Vo Thi Tuyet, Jarlais Don Des, Vinh Vu Hai, Nagot Nicolas, Laureillard Didier, Stone Jack, Vickerman Peter. Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, Vietnam.. The International journal on drug policy. 2025. DOI: 10.1016/j.drugpo.2025.104898.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.